Impact of macular edema on visual acuity in uveitis

被引:218
作者
Lardenoye, Charlotte W. T. A.
van Kooij, Bram
Rothova, Aniki
机构
[1] Univ Utrecht, Med Ctr, Dept Ophthalmol, FC Donders Inst, NL-3508 GA Utrecht, Netherlands
[2] St Elizabeth Hosp, Dept Ophthalmol, Tilburg, Netherlands
关键词
D O I
10.1016/j.ophtha.2006.03.027
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Objective: To investigate the impact of cystoid macular edema (CME) on visual acuity in patients with uveitis. Design: Cross-sectional study. Participants: The data from 529 patients (842 eyes) with uveitis were analyzed. Main Outcome Measures: We recorded gender and age of the patients, anatomic site and diagnosis of uveitis, associations with systemic diseases, onset and duration of uveitis, presence of CME, best-corrected visual acuity, and the causes of decrease in visual acuity. Results: Cystoid macular edema was noted in 175 (33%) of all uveitis patients, of whom 77 (44%) had visual acuity of 20/60 or less in at least 1 eye. The mean visual acuity for eyes with CME was significantly worse than for eyes without CME (0.25 vs. 0.4; P = 0.003). Of all uveitis patients, 185 (35%) had visual acuity of 20/60 or less in at least 1 eye, which was caused by CME in 77 (42%) patients. Poor visual acuity in patients with CME was associated with the advanced age of the patients, chronic inflammation, and various specific uveitis entities. The development of visually impaired or blind eyes in patients with panuveitis and intermediate uveitis was caused in most cases by CME (59% and 85%, respectively). Conclusions: Cystoid macular edema was a major cause of visual loss in patients with uveitis. The unsatisfactory visual acuity in patients with uveitis underlines the need for improved management of this complication. (c) 2006 by the American Academy of Ophthalmology.
引用
收藏
页码:1446 / 1449
页数:4
相关论文
共 21 条
  • [1] Chronic severe uveitis - Etiology and visual outcome in 927 patients from a single center
    Bodaghi, B
    Cassoux, N
    Wechsler, B
    Hannouche, D
    Fardeau, C
    Papo, T
    Huong, DLT
    Piette, JC
    LeHoang, P
    [J]. MEDICINE, 2001, 80 (04) : 263 - 270
  • [2] Prognosticators for visual outcome in sarcoid uveitis
    Dana, MR
    MerayoLloves, J
    Schaumberg, DA
    Foster, CS
    [J]. OPHTHALMOLOGY, 1996, 103 (11) : 1846 - 1853
  • [3] Degree, duration, and causes of visual loss in uveitis
    Durrani, OM
    Tehrani, NN
    Marr, JE
    Moradi, P
    Stavrou, P
    Murray, PI
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2004, 88 (09) : 1159 - 1162
  • [4] Birdshot retinochoroidopathy
    Gasch, AT
    Smith, JA
    Whitcup, SM
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 1999, 83 (02) : 241 - 249
  • [5] Indocyanine green and fundus fluorescein angiographic findings in patients with active ocular Behcet's disease
    Gedik, S
    Akova, YA
    Yilmaz, G
    Bozbeyoglu, S
    [J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2005, 13 (01) : 51 - 58
  • [6] Kanski JJ, 1994, CLIN OPHTHALMOLOGY S, P152
  • [7] Long-term follow-up of patients with birdshot retinochoroidopathy treated with corticosteroid-sparing systemic immunomodulatory therapy
    Kiss, S
    Ahmed, M
    Letko, E
    Foster, CS
    [J]. OPHTHALMOLOGY, 2005, 112 (06) : 1066 - 1071
  • [8] Kraut JA, 1994, PRINCIPLES PRACTICE, V5, P3664
  • [9] Visual loss in sarcoid-related uveitis
    Lobo, A
    Barton, K
    Minassian, D
    du Bois, RM
    Lightman, S
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2003, 31 (04) : 310 - 316
  • [10] Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis -: A study of 175 cases
    Monnet, D
    Breban, M
    Hudry, C
    Dougados, M
    Brézin, AP
    [J]. OPHTHALMOLOGY, 2004, 111 (04) : 802 - 809